SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding
SARS-CoV-2 antibodies is whether they mediate disease enhancement. Here, we isolated …

Betacoronaviruses caused the outbreaks of severe acute respiratory syndrome (SARS) and
Middle East respiratory syndrome, as well as the current pandemic of SARS coronavirus 2 (…

The first two mRNA vaccines against infection by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and were …

Defining the virus–host interactions responsible for HIV-1 transmission, including the phenotypic
requirements of viruses capable of establishing de novo infections, could be important …

A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant
genome-wide effect on HIV control in European Americans and is also associated with the level of …

Numerous genome-wide screens for polymorphisms that influence gene expression have
provided key insights into the genetic control of transcription. Despite this work, the relevance …

The initial antibody response to HIV-1 is targeted to envelope (Env) gp41, and is nonneutralizing
and ineffective in controlling viremia. To understand the origins and characteristics of …

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
multiple variants escaping preexisting immunity emerged, causing reinfections of previously …

Background During the recent H1N1 influenza pandemic, excess morbidity and mortality was
seen in young but not older adults suggesting that prior infection with influenza strains may …

In fall 2020, Duke University’s COVID-19 prevention strategy included risk reduction
behaviors, frequent testing using pooled SARS-CoV-2 polymerase chain reaction testing, and …